标准吉西他滨-顺铂联合治疗后转移性胆囊癌完全缓解
Complete Resolution of Metastatic Gallbladder Cancer after Standard Gemcitabine-Cisplatin Combination Therapy.
作者信息
Rho Young Soo, Barrera Ivan, Metrakos Peter, Kavan Petr
机构信息
Department of Oncology, McGill University Health Centre, Montreal, QC, Canada.
Department of Medical Oncology, Sir Mortimer B. Davis Jewish General Hospital, Segal Cancer Centre, McGill University, Montreal, QC, Canada.
出版信息
Cureus. 2015 Dec 17;7(12):e415. doi: 10.7759/cureus.415.
Gallbladder carcinoma (GBC) is a rare and deadly disease. The only curative option is a total surgical resection. If the disease is inoperable, palliative combination chemotherapy with gemcitabine-cisplatin remains the standard of care. We present here a case of a 47-year-old gentleman diagnosed with metastatic GBC who saw a complete resolution of his disease with seven cycles of standard gemcitabine-cisplatin chemotherapy. This case illustrates the importance of multidisciplinary care to explore all available options to provide optimal and tailored patient care.
胆囊癌（GBC）是一种罕见的致命疾病。唯一的治愈方法是进行完整的手术切除。如果疾病无法手术，吉西他滨-顺铂的姑息性联合化疗仍然是标准的治疗方法。我们在此介绍一例47岁男性转移性GBC患者，该患者在接受七个周期的标准吉西他滨-顺铂化疗后疾病完全缓解。该病例说明了多学科护理对于探索所有可用选项以提供最佳和个性化患者护理的重要性。
Zotero 插件